FutureFuel turns profitable in Q2 as revenue surges 120%
FutureFuel Corp achieved a return to profitability in Q2FY26 with $11.4 million net income and $78.7 million revenue, up 120.7% year-over-year. The turnaround was fueled by higher volumes in chemicals and biofuels, improved pricing, and regulatory tailwinds, alongside a $25 million customer-funded capacity expansion agreement.

*this image is generated using AI for illustrative purposes only.
FutureFuel Corp (NYSE: FF) returned to profitability in the second quarter of fiscal year 2026, reporting a net income of $11.4 million compared to a net loss of $14.2 million in the same period last year. The New York-listed manufacturer of custom chemicals and biofuels saw total revenues jump 120.7% to $78.7 million, driven by higher throughputs, improved pricing, and favorable regulatory clarity in the biofuels sector. This operational turnaround marks the company’s strongest financial performance since the fourth quarter of 2024, signaling a decisive shift from its previous loss-making trajectory.
The earnings per share (EPS) for the quarter stood at $0.25, a significant improvement from the $(0.32) loss per share recorded in Q2FY25. Adjusted EBITDA, a key non-GAAP metric used by management to assess operational liquidity, reached $11.8 million, up from a negative $11.4 million in the prior-year period. Chairman and CEO Roeland Polet attributed the turnaround to strengthening end-market demand, improved production economics, and enhanced optimization of the Batesville plant.
Segment Performance Breakdown
The revenue growth was broad-based across both core segments, though the Biofuels division contributed the larger share of the top-line increase.
| Segment | Q2FY26 Revenue | Q2FY25 Revenue | YoY Change |
|---|---|---|---|
| Chemicals | $25.8 million | $16.6 million | +55.5% |
| Biofuels | $52.9 million | $19.1 million | +178% |
| Total | $78.7 million | $35.7 million | +120.7% |
In the Chemicals segment, revenue rose primarily due to a 49% increase in volume/product mix effects and a 6% benefit from higher average prices. Custom chemical revenue grew 30% to $18.5 million, while performance chemical revenue surged 209% to $7.3 million, aided by a new customer that began production in late 2025. Gross profit for this segment improved to $5.0 million from $1.1 million in the prior year.
The Biofuels segment experienced a dramatic recovery, with gross profit turning positive at $10.1 million compared to a gross loss of $13.5 million in Q2FY25. Production increased 21% year-over-year despite a three-week biodiesel plant outage. Improved regulatory clarity surrounding Clean Fuel Production Credits and record-high renewable volume obligations incentivized domestic production, boosting sales volumes.
What the Numbers Show
The simultaneous surge in sales and the shift from negative to positive EPS suggests that FutureFuel has successfully leveraged its increased revenue volume to drive profitability. However, investors should note that the second-quarter results included a timing benefit related to ongoing biofuels hedging activity. Specifically, the sale of physical inventory at prices above hedged levels provided a $9.1 million benefit, which offset realized derivative losses recognized in the first quarter. Excluding these derivative impacts, the underlying operational improvement was driven by higher throughputs and better price realization in both segments.
Liquidity and Strategic Investments
Cash flow from operations strengthened significantly, reaching $18.8 million in Q2FY26, compared to $5.2 million in the prior-year period. As of June 30, 2026, the company held total cash and equivalents of $34.4 million, up from $22.4 million at the end of the first quarter. The company had no outstanding borrowings on its $35 million revolving credit facility.
Strategically, FutureFuel secured a four-year agreement to monetize Section 45Z Clean Fuel Production and Small Producer Tax Credits, expecting $22 million in gross proceeds during the second half of 2026. Additionally, an existing chemicals customer committed to investing $25 million in the Batesville facility in 2026, with up to $17 million more in 2027, to support incremental production capacity expected online in early fiscal 2028. Management anticipates delivering positive Adjusted EBITDA for the full year 2026.
How sustainable is FutureFuel's profitability given that Q2FY26 results included a $9.1 million timing benefit from hedging activities?
What specific operational milestones must be met for the Batesville facility to successfully integrate the new customer's $25 million investment and achieve incremental capacity by early FY28?
To what extent will the monetization of Section 45Z tax credits impact FutureFuel's cash flow stability and valuation multiples in the second half of 2026?




























